27.02.2013
- CordenPharma announces an expansion of manufacturing capabilities due to the recent acquisition by International Chemical Investors Group (ICIG) of Farchemia from the Tessenderlo...
27.02.2013
- UCB announced today its consolidated 2012 financial results. Revenue 2012 increased by 7% to €3 462 million, at constant exchange rates the increase was 2%. Net sales amounted to...
26.02.2013
- Swiss drugmaker Roche Holding has agreed to expand access to its clinical trial data as the pharmaceutical industry faces calls for greater transparency on scientific data. The...
26.02.2013
- The U.S. Food and Drug Administration said on Tuesday it has stopped all pediatric clinical trials of Amgen's Sensipar after the death of a 14-year-old patient taking part in a...
25.02.2013
- U.S.-based Affymax and Japan's Takeda Pharmaceutical said they are voluntarily recalling all lots of anemia treatment Omontys (peginesatide) in the United States due to reports of...
15.02.2013
- Merck & Co has agreed to pay $688 million to settle two U.S. class-action lawsuits by shareholders who said they lost money because the company concealed the poor results of a...
14.02.2013
- Swiss group Actelion has raised its dividend 25% as it awaits a U.S. regulatory decision on a new heart and lung drug it hopes will cut its dependency on current mainstay Tracleer...
13.02.2013
- An unusually severe cold and flu season in the United States helped drive full-year profits higher at Britain's Reckitt Benckiser, maker of Strepsils throat lozenges and Mucinex...
